| Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2012: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2011: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2010: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
|---|
| Research Abstract |
Kisspeptin is a bioactive peptide, which has been suggested to relate with cancers, hypogonadism, and perinatal disease. The author developed a sensitive enzyme immunoassay , which could measure blood kisspeptin concentrations, and tried to we identify diagnosable disease by plasma kisspeptin levels as a biomarker. Measuring and analysis of plasma/serum kisspeptin levels in healthy subjects and patients suggests that plasma kispeptin levels are expected to be a good biomarker for perinatal complication.
|
